A5DAL3 AF NFT

Pro-apoptotic serine protease NMA111

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibeddo5osaimqzqssbwebzi744b6q2fe5klgmrlhzno7yerevmed4/metadata.json
IPFS of structure file: 
bafybeigdpldrrtahhpwimdaq3bfo3aublec7js27le4ijz2ta55bkiuliy/AF-A5DAL3-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xdacb7C9769309e46da3ccf02C1e79fC50894f529
First NFT owner address (bech32): 
genesis1mt9he9mfxz0ydk3ueupvreulc5yffaff4vxkpg
Current NFT ID #266221 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
266221
Accession (UniProt):
A5DAL3
Name::
Pro-apoptotic serine protease NMA111
Experimental Method:
Predicted structure
Sequence source:
Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A5DAL3 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A5DAL3|NM111_PICGU Pro-apoptotic serine protease NMA111 OS=Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324) OX=294746 GN=NMA111 PE=3 SV=2 MTVGKRKLSNGTVNEAKRLDDHVPVVAPSTNPDFENANGEDNEDIDDYSSEGEMSPQLENYFPQTTSWQKTITKVVKSVVSIQFSHVSNFDTESSAVSEATGFVVDSERGYILTNRHVVGPGPFCGYVVFDNHEEAVVRPIYRDPIHDFGFLQFDPKDIRYMKIEQLDLRPDLAQVGTEIRVVGNDAGEKLSILAGFISRLDRNAPDYGTLSYNDFNTEYIQAAASASGGSSGSPVVNKEGYAVALQAGGSTEASTDFFLPVYRPLRALQCIQQGQTITRGDIQVEWQLKPFDECRRLGLTPEAEAAARSQFPDKIGLLVAELVLPEGPADGKLKEGDTLISINGTPIASFISVDEILDEQVGQSLKFVIQRNGHEVSFDIVVGDLHSITPSRYVDIAGASFNDLSYQVARCFCIPVRGVFINDGSGSFELSPFEKNGWLLEYVDDKPTPNLDAFVEVMKSIPDRKKVSISYRHVSDFHTENITVIYVERHWQSTFRMAVRNDSTGIWDFTDIQDKPLPAEEPVPQNAKYIDIPFDDPEKSGCSQLTRSFVQVRTIAPVPVDSYPYRREIGYGVVVDAANGYVLVSRRFVPHDMCDIFVIFAESVELPGKVVFLHPNQNYAIVKYDPKLMLADVKTPKFSDKPLKRGERAFFVGYNYNLRVVTDDVKVSSVSSINVPVASLSPRYRGTNLECILLDSKLSQECDSGVLADYDGTLRAFWITYLGETNCDQTNDRVYRMGLDVTDVMSVIKSLHENKVPAGLRILDAEFASMTIFQGRLRGVPQEWISKFEEVCEDEMKFLAVDRVSAPALGQVATPLKTGDIVMSVNGSIVKTMRDLGIMYNQDSLDFVVIRQKKELHLNVPTIDTSTLNTSHVVFWCGSILQAPHHGVRQLIEKIPSEIYVTKKNSGGPANQYGIATNSFITHVNDTETKTLESFVSVVKGIPDNTYIKLRLVSFDSIPVAISVKTNYHYFPTFELKKVNGEWEETEHKV